SCHEMBL6479653

SCHEMBL6479653

COc1ccc(N2CCN(C(=O)C=Cc3c(-c4ccccc4)n(C)c4ncccc34)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
HTT P42858 3/20 0.52
MAPT P10636 3/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
KDM4E B2RXH2 3/20 0.47
ABCB1 P08183 2/20 0.47
ABCG2 Q9UNQ0 1/20 0.47
KCNH2 Q12809 1/20 0.46
HDAC1 Q13547 1/20 0.46
ACHE P22303 2/20 0.46
LMNA P02545 2/20 0.44
TP53 P04637 1/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
GAA P10253 1/20 0.44
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
PDK1 Q15118 1/20 0.43
SIRT1 Q96EB6 1/20 0.43
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6479651 1.00 ALDH1A1 (0.52) ALDH1A1HTTMAPTL3MBTL1KDM4E
Hydrochloric Acid SCHEMBL6490279 0.81 SLC6A7 (0.48) ALDH1A1HTTMAPTL3MBTL1KDM4E
Hydrochloric Acid SCHEMBL6490276 0.81 SLC6A7 (0.48) ALDH1A1HTTMAPTL3MBTL1KDM4E
SCHEMBL6477745 0.79 ABCB1 (0.63) ALDH1A1MAPTKDM4EABCB1HDAC1
SCHEMBL6477751 0.79 ABCB1 (0.63) ALDH1A1MAPTKDM4EABCB1HDAC1
SCHEMBL30655963 0.78 ABCB1 (0.66) ALDH1A1MAPTKDM4EABCB1ACHE
SCHEMBL6479530 0.78 ABCB1 (0.66) ALDH1A1MAPTKDM4EABCB1ACHE
SCHEMBL29382296 0.78 ABCB1 (0.66) ALDH1A1MAPTKDM4EABCB1ACHE
SCHEMBL6479525 0.78 ABCB1 (0.66) ALDH1A1MAPTKDM4EABCB1ACHE
SCHEMBL30680371 0.78 ABCB1 (0.66) ALDH1A1MAPTKDM4EABCB1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014942-A1 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation NIPPON SHINYAKU CO., LTD. (JP) 2005-01-20 US disclosed
EP-1452525-A1 AMIDE DERIVATIVES AND DRUGS Nippon Shinyaku Co., Ltd. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014942-A1 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation TGFBR1, TGFBR2, TGFB1 ALDH1A1 2521/4885HTT 2388/4885MAPT 4750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.